2024 |
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria |
Articolo in rivista |
Vai |
2024 |
Factors Associated with Primary Liver Cancer Survival in a Southern Italian Setting in a Changing Epidemiological Scenario |
Articolo in rivista |
Vai |
2023 |
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination |
Articolo in rivista |
Vai |
2023 |
Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting |
Articolo in rivista |
Vai |
2023 |
Development of a Thalassemia International Prognostic Scoring System (TIPSS) |
Articolo in rivista |
Vai |
2023 |
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2023 |
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study |
Articolo in rivista |
Vai |
2023 |
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2022 |
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence |
Articolo in rivista |
Vai |
2022 |
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2022 |
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2022 |
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development |
Articolo in rivista |
Vai |
2022 |
Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals |
Articolo in rivista |
Vai |
2022 |
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis |
Articolo in rivista |
Vai |
2022 |
Protective benefit of minimally invasive liver surgery for hepatocellular carcinoma prior to transplant |
Articolo in rivista |
Vai |
2022 |
Hepatitis C: Standard of Treatment and What to Do for Global Elimination |
Articolo in rivista |
Vai |
2022 |
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis |
Articolo in rivista |
Vai |
2022 |
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices |
Articolo in rivista |
Vai |
2022 |
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD |
Articolo in rivista |
Vai |
2022 |
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders |
Articolo in rivista |
Vai |
2021 |
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes |
Articolo in rivista |
Vai |
2021 |
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease |
Articolo in rivista |
Vai |
2021 |
Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia |
Recensione in rivista |
Vai |
2021 |
Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience |
Articolo in rivista |
Vai |
2021 |
Perception of the role of food and dietary modifications in patients with inflammatory bowel disease: Impact on lifestyle |
Articolo in rivista |
Vai |
2021 |
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia |
Articolo in rivista |
Vai |
2021 |
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials |
Articolo in rivista |
Vai |
2021 |
Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C |
Articolo in rivista |
Vai |
2021 |
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach |
Articolo in rivista |
Vai |
2021 |
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2021 |
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy |
Articolo in rivista |
Vai |
2021 |
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population |
Articolo in rivista |
Vai |
2021 |
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort |
Articolo in rivista |
Vai |
2021 |
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study |
Articolo in rivista |
Vai |
2021 |
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C |
Articolo in rivista |
Vai |
2021 |
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals |
Articolo in rivista |
Vai |
2020 |
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2020 |
A complication risk score to evaluate clinical severity of thalassaemia syndromes |
Articolo in rivista |
Vai |
2020 |
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study |
Articolo in rivista |
Vai |
2020 |
Phylodynamic Analysis and Implication of HCV Genotype 4 Variability on Antiviral Drug Response and T-Cell Recognition |
Articolo in rivista |
Vai |
2020 |
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis |
Articolo in rivista |
Vai |
2020 |
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2020 |
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study |
Articolo in rivista |
Vai |
2020 |
Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver Tumors |
Articolo in rivista |
Vai |
2020 |
Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage |
Articolo in rivista |
Vai |
2020 |
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) |
Articolo in rivista |
Vai |
2020 |
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites |
Articolo in rivista |
Vai |
2020 |
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study |
Articolo in rivista |
Vai |
2020 |
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2019 |
Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Current epidemiology of HCV in Sicily: the RESIST-HCV model |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients |
Articolo in rivista |
Vai |
2019 |
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients |
Articolo in rivista |
Vai |
2019 |
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) |
Articolo in rivista |
Vai |
2019 |
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy |
Articolo in rivista |
Vai |
2019 |
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience |
Articolo in rivista |
Vai |
2019 |
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group. |
Articolo in rivista |
Vai |
2019 |
AISF position paper on HCV in immunocompromised patients |
Articolo in rivista |
Vai |
2019 |
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients |
Articolo in rivista |
Vai |
2019 |
Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience |
Articolo in rivista |
Vai |
2019 |
Update of the statements on biology and clinical impact of occult hepatitis B virus infection |
Articolo in rivista |
Vai |
2019 |
IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2019 |
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. |
Articolo in rivista |
Vai |
2018 |
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals |
Articolo in rivista |
Vai |
2018 |
Management of HCV-Related Liver Disease in Hemophilia and Thalassemia |
Articolo in rivista |
Vai |
2018 |
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. |
Articolo in rivista |
Vai |
2018 |
Breaking bad news: How to cope |
Lettera |
Vai |
2018 |
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents |
Articolo in rivista |
Vai |
2018 |
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population |
Articolo in rivista |
Vai |
2018 |
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. |
Articolo in rivista |
Vai |
2018 |
Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus. |
Articolo in rivista |
Vai |
2018 |
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals. |
Articolo in rivista |
Vai |
2018 |
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort |
Poster pubblicato in rivista |
Vai |
2018 |
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma. |
Articolo in rivista |
Vai |
2018 |
The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2018 |
Real life experiences in HCV management in 2018 |
Articolo in rivista |
Vai |
2018 |
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis |
Articolo in rivista |
Vai |
2018 |
Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus |
Articolo in rivista |
Vai |
2018 |
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis |
Articolo in rivista |
Vai |
2017 |
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2017 |
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response |
Articolo in rivista |
Vai |
2017 |
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel |
Articolo in rivista |
Vai |
2017 |
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2017 |
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD |
Articolo in rivista |
Vai |
2017 |
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study |
Articolo in rivista |
Vai |
2017 |
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication |
Articolo in rivista |
Vai |
2017 |
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2017 |
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity |
Articolo in rivista |
Vai |
2017 |
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies |
Articolo in rivista |
Vai |
2017 |
Current and future challenges in HCV: insights from an Italian experts panel |
Articolo in rivista |
Vai |
2017 |
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies |
Articolo in rivista |
Vai |
2017 |
Emerging Increase in the prevalence and severity of nonalcoholic fatty liver disease: epidemiological study from general Mediterranean population |
Abstract in atti di convegno pubblicato in rivista |
Vai |
2017 |
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values |
Articolo in rivista |
Vai |
2016 |
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2016 |
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension |
Articolo in rivista |
Vai |
2016 |
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model |
Articolo in rivista |
Vai |
2016 |
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. |
Articolo in rivista |
Vai |
2016 |
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels |
Articolo in rivista |
Vai |
2016 |
The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases |
Articolo in rivista |
Vai |
2016 |
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication? |
Articolo in rivista |
Vai |
2016 |
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2015 |
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease |
Articolo in rivista |
Vai |
2015 |
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease |
Articolo in rivista |
Vai |
2015 |
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. |
Articolo in rivista |
Vai |
2015 |
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C |
Articolo in rivista |
Vai |
2015 |
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis |
Articolo in rivista |
Vai |
2015 |
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity |
Abstract in rivista |
Vai |
2015 |
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program |
Articolo in rivista |
Vai |
2015 |
Impact of HBV genotypes A and D genetic variability on infection evolution |
Articolo in rivista |
Vai |
2015 |
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis |
Articolo in rivista |
Vai |
2015 |
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2015 |
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome |
Articolo in rivista |
Vai |
2015 |
Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis. |
Articolo in rivista |
Vai |
2014 |
Targeted Therapies in Hepatocellular Carcinoma |
Articolo in rivista |
Vai |
2014 |
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin |
Articolo in rivista |
Vai |
2014 |
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2014 |
HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors |
Articolo in rivista |
Vai |
2014 |
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2014 |
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene |
Abstract in rivista |
Vai |
2014 |
EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN
HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED
FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY
ACCESS PROGRAM |
Proceedings |
Vai |
2014 |
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2013 |
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B |
Articolo in rivista |
Vai |
2013 |
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Vai |
2013 |
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal
varices in patients with compensated hepatitis C virus cirrhosis |
Articolo in rivista |
Vai |
2013 |
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Proceedings |
Vai |
2013 |
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease |
Articolo in rivista |
Vai |
2013 |
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection |
Articolo in rivista |
Vai |
2013 |
Survival of Patients with Hepatocellular Carcinoma (HCC)
Treated by Percutaneous Radio-Frequency Ablation
(RFA) Is Affected by Complete Radiological Response |
Abstract in rivista |
Vai |
2013 |
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients |
Articolo in rivista |
Vai |
2013 |
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance |
Articolo in rivista |
Vai |
2013 |
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2013 |
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. |
Articolo in rivista |
Vai |
2013 |
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC |
Abstract in rivista |
Vai |
2013 |
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis |
Abstract in rivista |
Vai |
2013 |
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis. |
Articolo in rivista |
Vai |
2013 |
Sorafenib: from literature to clinical practice |
Articolo in rivista |
Vai |
2012 |
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study |
Articolo in rivista |
Vai |
2012 |
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. |
Articolo in rivista |
Vai |
2012 |
Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up. |
Articolo in rivista |
Vai |
2012 |
IL28B polymorphisms influence stage of fibrosis and
spontaneous or interferon-induced viral clearance in thalassemia patients with
hepatitis C virus infection. |
Articolo in rivista |
Vai |
2012 |
HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years |
Articolo in rivista |
Vai |
2012 |
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with
Genotype 1 Chronic Hepatitis C |
Articolo in rivista |
Vai |
2012 |
Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in
patients with chronic liver diseases. |
Articolo in rivista |
Vai |
2012 |
IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. |
Articolo in rivista |
Vai |
2012 |
Current practice of chronic hepatitis B treatment in Southern Italy. |
Articolo in rivista |
Vai |
2012 |
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C |
Articolo in rivista |
Vai |
2012 |
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. |
Articolo in rivista |
Vai |
2012 |
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease |
Articolo in rivista |
Vai |
2012 |
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV |
Abstract in rivista |
Vai |
2012 |
Methylenetetrahydrofolate reductase homozygosis
and low-density lipoproteins in patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2012 |
Hyperuricaemia:
another metabolic feature affecting the severity of chronic hepatitis because of
HCV infection. |
Articolo in rivista |
Vai |
2011 |
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases |
Articolo in rivista |
Vai |
2011 |
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. |
Articolo in rivista |
Vai |
2011 |
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. |
Articolo in rivista |
Vai |
2011 |
Predicting survival in patients with hepatocellular carcinoma
treated by transarterial chemoembolisation |
Articolo in rivista |
Vai |
2011 |
Predicting survival in patients with hepatocellular carcinoma
treated by transarterial chemoembolisation |
Articolo in rivista |
Vai |
2011 |
Chronic hepatitis C in children is a mild and curable liver disease |
Recensione in rivista |
Vai |
2011 |
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. |
Articolo in rivista |
Vai |
2011 |
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis |
Articolo in rivista |
Vai |
2011 |
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance |
Abstract in rivista |
Vai |
2011 |
Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. |
Articolo in rivista |
Vai |
2011 |
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis |
Recensione in rivista |
Vai |
2011 |
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. |
Articolo in rivista |
Vai |
2011 |
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
2011 |
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. |
Articolo in rivista |
Vai |
2011 |
Treatment of chronic
hepatitis B: update of the recommendations from the 2007 Italian Workshop |
Articolo in rivista |
Vai |
2011 |
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE |
Abstract in rivista |
Vai |
2011 |
LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION |
Abstract in rivista |
Vai |
2011 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Vai |
2011 |
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy |
Articolo in rivista |
Vai |
2010 |
INSULIN RESISTANCE, STEATOSIS AND PROGRESSION OF FIBROSIS IN PATIENTS WITH GENOTYPE 1 CHRONIC
HEPATITIS C |
Proceedings |
Vai |
2010 |
HEPATIC STEATOSIS IS ASSOCIATED WITH SEVERE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B |
Proceedings |
Vai |
2010 |
Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. |
Articolo in rivista |
Vai |
2010 |
Halitosis: could it be more than mere bad breath? |
Articolo in rivista |
Vai |
2010 |
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. |
Articolo in rivista |
Vai |
2010 |
Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. |
Articolo in rivista |
Vai |
2010 |
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C |
Abstract in rivista |
Vai |
2010 |
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? |
Abstract in rivista |
Vai |
2010 |
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2009 |
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. |
Articolo in rivista |
Vai |
2009 |
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings |
Vai |
2009 |
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. |
Articolo in rivista |
Vai |
2009 |
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection |
Articolo in rivista |
Vai |
2009 |
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response |
Proceedings |
Vai |
2009 |
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy |
Articolo in rivista |
Vai |
2009 |
Chronic hepatitis B: who to treat and which choice of treatment? |
Articolo in rivista |
Vai |
2009 |
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis |
Articolo in rivista |
Vai |
2009 |
Time course of insulin resistance during antiviral
therapy in non-diabetic, non-cirrhotic patients with
genotype 1 HCV infection |
Articolo in rivista |
Vai |
2009 |
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in
chronic hepatitis C |
Articolo in rivista |
Vai |
2009 |
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? |
Articolo in rivista |
Vai |
2009 |
Histomorphology of healthy oral mucosa in untreated celiac patients: unexpected association with spongiosis. |
Articolo in rivista |
Vai |
2009 |
Hyperferritinemia is a risk factor
for steatosis in chronic liver disease. |
Articolo in rivista |
Vai |
2009 |
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE |
Abstract in rivista |
Vai |
2009 |
HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION |
Abstract in rivista |
Vai |
2009 |
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus
cirrhosis. |
Articolo in rivista |
Vai |
2008 |
Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome |
Proceedings |
Vai |
2008 |
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. |
Articolo in rivista |
Vai |
2008 |
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay |
Articolo in rivista |
Vai |
2008 |
Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. |
Articolo in rivista |
Vai |
2008 |
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
2008 |
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS |
Articolo in rivista |
Vai |
2008 |
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. |
Articolo in rivista |
Vai |
2008 |
CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY |
Proceedings |
Vai |
2008 |
Metformina e pioglitazone in soggetti affetti da diabete mellito tipo 2 con steatosi epatica |
Proceedings |
Vai |
2008 |
Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease |
Proceedings |
Vai |
2008 |
Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease |
Proceedings |
Vai |
2008 |
Insulin resistance and diabetes increase fibrosis in the liver of patients with
genotype 1 HCV infection. |
Articolo in rivista |
Vai |
2008 |
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems |
Articolo in rivista |
Vai |
2008 |
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis |
Articolo in rivista |
Vai |
2008 |
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C |
Articolo in rivista |
Vai |
2007 |
Seeding after radiofrequency thermal ablation of hepatocellular carcinoma in cirrhosis: a prospective study |
Proceedings |
Vai |
2007 |
Oral pathology in untreated coeliac disease |
Articolo in rivista |
Vai |
2007 |
Oral Mucosa of celiac disease patients produces anti-endomysial and anti-transglutaminase antibodes. Diagnostic usefulness of an in vitro culture system |
Articolo in rivista |
Vai |
2007 |
HCV clearance among hemophiliacs and beta-thalassemics |
Abstract in rivista |
Vai |
2007 |
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study |
Proceedings |
Vai |
2007 |
INSULIN RESISTANCE AND SEVERITY OF
FIBROSIS IN HCV GENOTYPE 1 CHRONIC HEPATITIS. |
Proceedings |
Vai |
2007 |
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD |
Proceedings |
Vai |
2007 |
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study |
Proceedings |
Vai |
2007 |
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner |
Proceedings |
Vai |
2007 |
Adefovir for lamivudine resistant HBV: More than meets the eye. |
Articolo in rivista |
Vai |
2007 |
Oral Mucosa of celiac patients produces anti-endomysial and anti-transglutaminase antibodies. Diagnostic usefulness of an in vitro culture system. |
Proceedings |
Vai |
2007 |
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial |
Articolo in rivista |
Vai |
2007 |
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier |
Proceedings |
Vai |
2007 |
VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS |
Proceedings |
Vai |
2007 |
Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale |
Proceedings |
Vai |
2007 |
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. |
Articolo in rivista |
Vai |
2007 |
Prophylaxis and treatment of hepatitis B in immunocompromised patients. |
Articolo in rivista |
Vai |
2007 |
INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITA’ VIRALE |
Proceedings |
Vai |
2006 |
Halitosis and HCV-related liver disease:true association |
Proceedings |
Vai |
2006 |
Suggestive caratteristiche istomorfologiche della mucosa orale sana in pazienti affetti da morbo celiaco vs pazienti non celiaci:studio caso-controllo. |
Proceedings |
Vai |
2006 |
A muticenter Italian Study od rescue adefovir dipivoxil therapy in lamivudine resistant patients: a 2 years analysis of 650 pATIENTS. |
Articolo in rivista |
Vai |
2006 |
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C |
Articolo in rivista |
Vai |
2006 |
Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis. |
Articolo in rivista |
Vai |
2006 |
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. |
Articolo in rivista |
Vai |
2006 |
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial |
Articolo in rivista |
Vai |
2006 |
High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C |
Articolo in rivista |
Vai |
2006 |
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. |
Articolo in rivista |
Vai |
2006 |
Histomorphological features of health oral mucosa in celiac patients:unexspected association with spongiosis. |
Proceedings |
Vai |
2006 |
Histomorphological features of healthy oral mucosa in coeliac patients: unexpected association with spongiosis”. |
Proceedings |
Vai |
2006 |
Adefovir and Lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B |
Articolo in rivista |
Vai |
2005 |
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir |
Proceedings |
Vai |
2005 |
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy |
Articolo in rivista |
Vai |
2005 |
Current epidemiological trends and outcome in a large cohort of acute hepatitis C patients. |
Articolo in rivista |
Vai |
2005 |
A multicenter Italian Study of rescue adefovir dipivoxil tehrapy in lamivudine resistant patients: a 2-year anlysis of 604 patients. |
Articolo in rivista |
Vai |
2005 |
Congenital hepatic fibrosis: a very uncommon cause of pancytopenia in children. |
Articolo in rivista |
Vai |
2005 |
Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center |
Articolo in rivista |
Vai |
2005 |
Infezione occulta da HBV in pazienti con malattie oncoematologiche |
Proceedings |
Vai |
2005 |
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) |
Proceedings |
Vai |
2005 |
Caratterizzazione biochimica e molecolare di ceppi di Mannheimia isolati da ovini siciliani. |
Proceedings |
Vai |
2005 |
Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b |
Articolo in rivista |
Vai |
2005 |
Valutazione della clearance di HCV-RNA sotto trattamentio antivirale con Transcription-Mediated Amplification (TMA) |
Proceedings |
Vai |
2005 |
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study |
Articolo in rivista |
Vai |
2004 |
Patologie da sovraccarico di ferro:recenti acquisizioni |
Articolo in rivista |
Vai |
2004 |
The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing |
Abstract in rivista |
Vai |
2004 |
Emocromatosi |
Articolo in rivista |
Vai |
2004 |
Percutaneous radiofrequency therma ablation of small hepatocellular carcinoma: a prospective study |
Proceedings |
Vai |
2004 |
PERCUTANEOUS RADIOFREQUENCY THERMAL ABLATION 8 RFTA) OF SMALL HEPATOCELLUALR CARCINOMA: A PROSPECTIVE STUDY |
Articolo in rivista |
Vai |
2004 |
Caratterizzazione molecolare di ceppi di Mannheimia isolati da ovini siciliani |
Altro |
Vai |
2004 |
La termoablazione nel trattamento delle neoplasie epatiche primitive e secondarie |
Articolo in rivista |
Vai |
2004 |
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine |
Articolo in rivista |
Vai |
2004 |
PATTERNS DI RECIDIVA EPATICA CON MDCT DOPO TERMOABLAZIONE A RADIOFRAQUENZA |
Proceedings |
Vai |
2004 |
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin |
Articolo in rivista |
Vai |
2004 |
Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial |
Articolo in rivista |
Vai |
2004 |
Paraduodenal hernia: an uncommon cause of recurrent abdominal pain |
Articolo in rivista |
Vai |
2004 |
Combination therapy with amantadine and interferon in naive patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials |
Articolo in rivista |
Vai |
2004 |
Caratterizzazione molecolare di ceppi di Mannheimia isolati da ovini siciliani |
Proceedings |
Vai |
2003 |
A patient with acute hepatitis C and possible IFN toxicity [2] |
Articolo in rivista |
Vai |
2003 |
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV |
Articolo in rivista |
Vai |
2003 |
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin |
Articolo in rivista |
Vai |
2003 |
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C |
Articolo in rivista |
Vai |
2002 |
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction |
Articolo in rivista |
Vai |